[go: up one dir, main page]

DK1105136T3 - Fremgangsmåde til behandling af okulære neovaskulære sygdomme - Google Patents

Fremgangsmåde til behandling af okulære neovaskulære sygdomme

Info

Publication number
DK1105136T3
DK1105136T3 DK99944371T DK99944371T DK1105136T3 DK 1105136 T3 DK1105136 T3 DK 1105136T3 DK 99944371 T DK99944371 T DK 99944371T DK 99944371 T DK99944371 T DK 99944371T DK 1105136 T3 DK1105136 T3 DK 1105136T3
Authority
DK
Denmark
Prior art keywords
treating ocular
ocular neovascular
neovascular disease
disease
treating
Prior art date
Application number
DK99944371T
Other languages
Danish (da)
English (en)
Inventor
Romulus Kimbro Brazzell
Jeanette Marjorie Wood
Peter Anthony Campochiaro
Frances Elizabeth Kane
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22460608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1105136(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1105136T3 publication Critical patent/DK1105136T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99944371T 1998-08-13 1999-08-11 Fremgangsmåde til behandling af okulære neovaskulære sygdomme DK1105136T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13385598A 1998-08-13 1998-08-13
PCT/EP1999/005876 WO2000009098A2 (fr) 1998-08-13 1999-08-11 Methode de traitement de maladies oculaires neovasculaires

Publications (1)

Publication Number Publication Date
DK1105136T3 true DK1105136T3 (da) 2007-10-15

Family

ID=22460608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944371T DK1105136T3 (da) 1998-08-13 1999-08-11 Fremgangsmåde til behandling af okulære neovaskulære sygdomme

Country Status (12)

Country Link
EP (1) EP1105136B1 (fr)
JP (1) JP2002522475A (fr)
AR (1) AR028802A1 (fr)
AT (1) ATE371453T1 (fr)
AU (1) AU5733099A (fr)
CY (1) CY1107780T1 (fr)
DE (1) DE69936994T2 (fr)
DK (1) DK1105136T3 (fr)
ES (1) ES2291041T3 (fr)
PT (1) PT1105136E (fr)
TW (1) TWI239243B (fr)
WO (1) WO2000009098A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
DE69838172T2 (de) 1997-08-22 2008-04-10 Astrazeneca Ab Oxindolylchinazolinderivate als angiogenesehemmer
AU766081B2 (en) * 1999-03-30 2003-10-09 Novartis Ag Phthalazine derivatives for treating inflammatory diseases
US7087608B2 (en) 2000-03-03 2006-08-08 Robert Charles Atkins Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
JP2004537536A (ja) 2001-06-29 2004-12-16 アブ サイエンス アレルギー疾患を治療するためのチロシンキナーゼ阻害剤の使用方法
US7741335B2 (en) 2001-06-29 2010-06-22 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory diseases
US7678805B2 (en) 2001-06-29 2010-03-16 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
JP2005500041A (ja) 2001-06-29 2005-01-06 アブ サイエンス 強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
US20060204459A1 (en) * 2001-09-20 2006-09-14 Alain Moussy Use of tyrosine inhibitors for whitening human skin and treating melanocyted dysfunction associated diseases
BR0308053A (pt) * 2002-02-28 2004-12-28 Novartis Ag Stents revestidos com n-{5-[4-(4-metil-piperazino-metil)-benzoilamido]-2-metil fenil}-4-(3-piridil)-2-pirimidina-amina
US20050209237A1 (en) * 2002-04-30 2005-09-22 Brazzell Romulus K Method for decreasing capillary permeability in the retina
EP2125895B1 (fr) 2007-02-02 2015-04-08 Vegenics Pty Ltd Antagoniste du recepteur de facteurs de croissance pour l'allo-immunite de greffe d'organe et l'arteriosclerose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09316099A (ja) * 1995-08-21 1997-12-09 Mitsui Petrochem Ind Ltd 抗ｖｅｇｆヒトモノクローナル抗体
WO1997034876A1 (fr) * 1996-03-15 1997-09-25 Zeneca Limited Derives de cinnoline et leur emploi comme medicaments
AU2066797A (en) * 1996-03-21 1997-10-10 Sugen, Inc. Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
JPH1031019A (ja) * 1996-07-15 1998-02-03 Toagosei Co Ltd 糖尿病性血管新生緑内障の検査方法及び検査薬
CA2263479A1 (fr) * 1996-09-25 1998-04-02 Zeneca Limited Derives quinolines inhibant les effets de facteurs de croissance tels que le facteur de croissance endotheliale vasculaire
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

Also Published As

Publication number Publication date
AU5733099A (en) 2000-03-06
TWI239243B (en) 2005-09-11
DE69936994D1 (de) 2007-10-11
CY1107780T1 (el) 2013-06-19
ATE371453T1 (de) 2007-09-15
DE69936994T2 (de) 2008-06-05
JP2002522475A (ja) 2002-07-23
WO2000009098A3 (fr) 2000-05-18
ES2291041T3 (es) 2008-02-16
AR028802A1 (es) 2003-05-28
EP1105136B1 (fr) 2007-08-29
PT1105136E (pt) 2007-12-03
WO2000009098A2 (fr) 2000-02-24
EP1105136A2 (fr) 2001-06-13

Similar Documents

Publication Publication Date Title
DK0914103T3 (da) Behandling af hæmoglobinopati
ID24320A (id) Turunan-turunan benzopiran tersubstitusi untuk pengobatan radang
DK1121192T3 (da) Fremgangsmåde til homogenisering
DK1077940T3 (da) 4-Phenylpiperidiner til behandling af pruritiske dermatoser
FI20000863L (fi) Uusi hoitomenetelmä
ID26990A (id) Metode pembuatan dimetilnaftalena
NO20002075L (no) FremgangsmÕte ved aminering
DK0788310T3 (da) Fremgangsmåde til inhibering af plantesygdom
DK1105136T3 (da) Fremgangsmåde til behandling af okulære neovaskulære sygdomme
DE69912949D1 (de) Entwässerungsverfahren
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ID19570A (id) Metode merawat tanaman kotiledonous
DK0987356T3 (da) Fremgangsmåde til trækning
ID19540A (id) Metode pembuatan turunan-turunan benzofenon
ID16924A (id) Metode perlakuan poliolefin
DE69931682D1 (de) Verbrennungsmethode
NO20006383L (no) Fremgangsmåte for behandling
ID23019A (id) Metode pembuatan turunan nitroguadinin
DE69908572D1 (de) Behandlung von metallen
ATE366573T1 (de) Neue behandlungsmethode
MD676F1 (ro) Metoda de tratament al rinosinuzitelor Method for treatment of the rhinosinusitis
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки
SE9802791D0 (sv) Behandlingsmetod
ID26641A (id) Metoda pengobatan
SE9802223D0 (sv) Method of application